about
Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Biological Response Modifier in Cancer Immunotherapy.The diagnostic effect of serum miR-196b as biomarker in colorectal cancermiR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective studyPlasma microRNA signature is associated with risk stratification in prostate cancer patients.miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3.Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression.Serum microRNA expression profiling in patients with multiple system atrophy.miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma.Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysisDifferent signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patientsExosomal microRNAs as tumor markers in epithelial ovarian cancer
P2860
Q30847181-56EED098-3081-4B40-BDEC-F902C2CBBCF5Q36546019-8DCF6CCC-D2F4-453C-9382-BDA20C3F0343Q38652482-196D98C8-0610-41CD-9185-A5CE5E96668EQ38707876-5AB77146-BEEC-416B-9F48-D7BE1B57779AQ38848213-C807503C-C6BD-4828-A81D-75F11F0CC9CAQ38998550-183ED51E-D113-4361-9621-FB81A2566A4EQ40058632-C4C06758-D6D6-45B5-950E-DE21B702096AQ41024459-6722AD7C-671E-42C1-9B9D-14AD0A2A0761Q41346526-FA21C198-6DAF-4DA1-92B2-1F33FDE14B52Q48342435-A591B0C5-8B72-48A7-9763-CC747BB6D7F3Q48515407-B5301B90-DE4C-4B99-BC70-F64C3806A0B2Q49272569-01F37B32-29BE-4B83-9116-A57D68C76EFCQ49639919-6653A001-C87E-4071-B929-0871163D56B1Q55644580-4D51E4BA-935D-477C-8199-48B6E234EED6Q57173336-591250CD-2602-4816-AFD1-DB2A8130095DQ58699582-6EE75980-65EB-4B67-B21F-B1CE114E7264Q58776553-92460188-2CA7-4AF9-8D4A-3339E2B43CCD
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miRNA-15a/16: as tumor suppressors and more.
@en
type
label
miRNA-15a/16: as tumor suppressors and more.
@en
prefLabel
miRNA-15a/16: as tumor suppressors and more.
@en
P2093
P2860
P356
P1433
P1476
miRNA-15a/16: as tumor suppressors and more.
@en
P2093
Enyu Huang
Ronghua Liu
P2860
P304
P356
10.2217/FON.15.101
P407
P577
2015-08-01T00:00:00Z